Bifogade filer
Kurs & Likviditet
Kalender
2023-10-26 | Kvartalsrapport 2023-Q3 |
2023-07-17 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-03-23 | Ordinarie utdelning ORNBV 1.60 EUR |
2023-03-23 | Ordinarie utdelning ORNAV 1.60 EUR |
2023-03-22 | Årsstämma 2023 |
2023-02-09 | Bokslutskommuniké 2022 |
2022-10-20 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-03-24 | Ordinarie utdelning ORNBV 1.50 EUR |
2022-03-24 | Ordinarie utdelning ORNAV 1.50 EUR |
2022-03-23 | Årsstämma 2022 |
2022-02-10 | Bokslutskommuniké 2021 |
2021-10-20 | Kvartalsrapport 2021-Q3 |
2021-07-19 | Kvartalsrapport 2021-Q2 |
2021-04-27 | Kvartalsrapport 2021-Q1 |
2021-03-26 | Ordinarie utdelning ORNAV 1.50 EUR |
2021-03-26 | Ordinarie utdelning ORNBV 1.50 EUR |
2021-03-25 | Årsstämma 2021 |
2021-02-09 | Bokslutskommuniké 2020 |
2020-10-21 | Kvartalsrapport 2020-Q3 |
2020-07-17 | Kvartalsrapport 2020-Q2 |
2020-05-07 | Ordinarie utdelning ORNBV 1.50 EUR |
2020-05-07 | Ordinarie utdelning ORNAV 1.50 EUR |
2020-05-06 | Årsstämma 2020 |
2020-04-28 | Kvartalsrapport 2020-Q1 |
2020-03-26 | Ordinarie utdelning ORNBV 1.50 EUR |
2020-02-05 | Bokslutskommuniké 2019 |
2019-10-23 | Kvartalsrapport 2019-Q3 |
2019-07-17 | Kvartalsrapport 2019-Q2 |
2019-04-25 | Kvartalsrapport 2019-Q1 |
2019-03-27 | Ordinarie utdelning ORNBV 1.50 EUR |
2019-03-27 | Ordinarie utdelning ORNAV 1.50 EUR |
2019-03-26 | Årsstämma 2019 |
2019-02-06 | Bokslutskommuniké 2018 |
2018-10-24 | Kvartalsrapport 2018-Q3 |
2018-07-18 | Kvartalsrapport 2018-Q2 |
2018-04-24 | Kvartalsrapport 2018-Q1 |
2018-03-21 | Ordinarie utdelning ORNAV 1.45 EUR |
2018-03-21 | Ordinarie utdelning ORNBV 1.45 EUR |
2018-03-20 | Årsstämma 2018 |
2018-02-07 | Bokslutskommuniké 2017 |
2017-10-26 | Kvartalsrapport 2017-Q3 |
2017-07-19 | Kvartalsrapport 2017-Q2 |
2017-05-18 | Kapitalmarknadsdag 2017 |
2017-04-26 | Kvartalsrapport 2017-Q1 |
2017-03-23 | Bonusutdelning ORNBV 0.2 |
2017-03-23 | Ordinarie utdelning ORNBV 1.35 EUR |
2017-03-23 | Ordinarie utdelning ORNAV 1.35 EUR |
2017-03-23 | Bonusutdelning ORNAV 0.2 |
2017-03-22 | Årsstämma 2017 |
2017-02-08 | Bokslutskommuniké 2016 |
2016-10-25 | Kvartalsrapport 2016-Q3 |
2016-07-19 | Kvartalsrapport 2016-Q2 |
2016-04-27 | Kvartalsrapport 2016-Q1 |
2016-03-23 | Ordinarie utdelning ORNAV 1.30 EUR |
2016-03-23 | Ordinarie utdelning ORNBV 1.30 EUR |
2016-03-22 | Årsstämma 2016 |
2016-02-02 | Bokslutskommuniké 2015 |
2015-10-27 | Kvartalsrapport 2015-Q3 |
2015-07-28 | Kvartalsrapport 2015-Q2 |
2015-05-26 | Kapitalmarknadsdag 2015 |
2015-04-29 | Kvartalsrapport 2015-Q1 |
2015-03-25 | Ordinarie utdelning ORNAV 1.30 EUR |
2015-03-25 | Ordinarie utdelning ORNBV 1.30 EUR |
2015-03-24 | Årsstämma 2015 |
2015-02-04 | Bokslutskommuniké 2014 |
2014-10-21 | Kvartalsrapport 2014-Q3 |
2014-07-29 | Kvartalsrapport 2014-Q2 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-03-26 | Ordinarie utdelning ORNBV 1.25 EUR |
2014-03-26 | Ordinarie utdelning ORNAV 1.25 EUR |
2014-03-25 | Årsstämma 2014 |
2014-02-04 | Bokslutskommuniké 2013 |
2013-10-22 | Kvartalsrapport 2013-Q3 |
2013-07-30 | Kvartalsrapport 2013-Q2 |
2013-04-23 | Kvartalsrapport 2013-Q1 |
2013-03-20 | Ordinarie utdelning ORNBV 1.30 EUR |
2013-03-20 | Ordinarie utdelning ORNAV 1.30 EUR |
2013-03-19 | Årsstämma 2013 |
2013-02-05 | Bokslutskommuniké 2012 |
2012-10-23 | Kvartalsrapport 2012-Q3 |
2012-07-31 | Kvartalsrapport 2012-Q2 |
2012-05-24 | Kapitalmarknadsdag 2012 |
2012-04-24 | Kvartalsrapport 2012-Q1 |
2012-03-21 | Bonusutdelning ORNBV 0.12 |
2012-03-21 | Bonusutdelning ORNAV 0.12 |
2012-03-21 | Ordinarie utdelning ORNBV 1.30 EUR |
2012-03-21 | Ordinarie utdelning ORNAV 1.30 EUR |
2012-03-20 | Årsstämma 2012 |
2012-02-07 | Bokslutskommuniké 2011 |
2011-10-25 | Kvartalsrapport 2011-Q3 |
2011-08-02 | Kvartalsrapport 2011-Q2 |
2011-04-01 | Ordinarie utdelning ORNAV 1.20 EUR |
2011-04-01 | Bonusutdelning ORNBV 0.06 |
2011-04-01 | Bonusutdelning ORNAV 0.06 |
2011-04-01 | Ordinarie utdelning ORNBV 1.20 EUR |
2010-03-25 | Bonusutdelning ORNBV 0.1 |
2010-03-25 | Bonusutdelning |
2010-03-25 | Ordinarie utdelning ORNBV 1.00 EUR |
2010-03-25 | Ordinarie utdelning |
2009-03-24 | Ordinarie utdelning |
2009-03-24 | Ordinarie utdelning ORNBV 0.95 EUR |
2008-03-26 | Ordinarie utdelning ORNBV 1.00 EUR |
2007-04-03 | Ordinarie utdelning |
2007-04-03 | Ordinarie utdelning ORNBV 1.00 EUR |
2006-03-22 | Ordinarie utdelning ORNBV 0.85 EUR |
2005-03-22 | Ordinarie utdelning |
2005-03-22 | Ordinarie utdelning ORNBV 0.55 EUR |
2004-09-15 | Bonusutdelning |
2004-09-15 | Bonusutdelning ORNBV 2.14 |
2004-03-23 | Ordinarie utdelning |
2004-03-23 | Ordinarie utdelning ORNBV 1.60 EUR |
2003-12-12 | Bonusutdelning ORNBV 1.5 |
2003-12-12 | Bonusutdelning |
2003-03-23 | Ordinarie utdelning |
2003-03-23 | Ordinarie utdelning ORNBV 0.93 EUR |
2002-04-16 | Ordinarie utdelning |
2002-04-16 | Ordinarie utdelning ORNBV 1.10 EUR |
2001-03-30 | Ordinarie utdelning |
2001-03-30 | Ordinarie utdelning ORNBV 1.20 EUR |
2000-03-31 | Ordinarie utdelning ORNBV 1.18 EUR |
2000-03-31 | Ordinarie utdelning |
1999-07-28 | Bonusutdelning |
1999-07-28 | Bonusutdelning |
1999-04-09 | Ordinarie utdelning |
1999-04-09 | Ordinarie utdelning |
1998-04-21 | Ordinarie utdelning |
1998-04-21 | Ordinarie utdelning |
1997-04-22 | Ordinarie utdelning |
1997-04-22 | Ordinarie utdelning |
1996-04-23 | Ordinarie utdelning |
1996-04-23 | Ordinarie utdelning |
Beskrivning
Land | Finland |
---|---|
Lista | Large Cap Helsinki |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
ORION CORPORATION
STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS
20 SEPTEMBER 2022 at 13.15 EEST
Change in Orion Group Executive Management Board as of 1 November 2022 – Juhani Kankaanpää appointed as Senior Vice President of Global Operations
Juhani Kankaanpää has been appointed as Senior Vice President, Global Operations, and member of the Executive Management Board of Orion Group as of 1 November 2022. Mr. Kankaanpää has been working in management positions at Orion since 2016 with responsibility for, among other things, developing operational activities, leading the controller team and leading the Orion Group's strategy process. He is currently responsible for the integration of Orion Animal Health and the acquired veterinary pharmaceutical company Inovet (VMD). Previously, he has held several operational management positions at Orkla, and has worked as a consultant at The Boston Consulting Group. Mr Kankaanpää holds a Master of Science in Technology (industrial engineering and management) degree.
“I am delighted that Juhani will lead Orion's operational activities. He has extensive experience in operations and in the different functions and the whole of Orion. I wish Juhani every success in his new role”, says SVP, Global Operations, Liisa Hurme who will start as Orion’s President and CEO on 1 November 2022.
“I am excited and grateful for this appointment, and I look forward to the new tasks ahead. I am familiar with Orion's operations from my previous roles and the staff there are highly competent. I look forward to working with them and developing Orion together”, says Juhani Kankaanpää.
Orion Corporation
Timo Lappalainen President and CEO | Olli Huotari SVP, Corporate Functions |
Contact person:
Liisa Hurme, SVP, Global Operations, Orion’s President and CEO as of 1 November 2022
tel. +358 10 426 2874
Contact person for media:
Terhi Ormio, Vice President, Communications
phone +358 50 966 4646, terhi.ormio@orion.fi
ANNEX: The CV of Juhani Kankaanpää
Juhani Kankaanpää
Born 1980
Education
Master of Science in Technology, Aalto University, 2006
Career
2022– Director, Integration of Orion Animal Health and Inovet (VMD), Orion Corporation
2021–2022 Director, Strategy and Business Planning, Orion Corporation
2016–2021 Director, Operations Development, Orion Corporation
2013–2016 Project Leader, The Boston Consulting Group
2011–2013 Operations Director, Orkla Foods Finland
2010–2011 Plant Director, Felix Abba Oy (Orkla Group)
2009–2010 Plant Manager, Felix Abba Oy (Orkla Group)
2008–2009 Project Manager, Orkla Foods Fenno-Baltic Corporate Development
2006–2008 Consultant, BearingPoint consulting
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.